lassa
viru
lasv
caus
agent
lassa
fever
respons
sever
hundr
thousand
infect
thousand
death
annual
west
africa
lasv
nonpathogen
mopeia
viru
mopv
rodentborn
african
arenavirus
live
attenu
reassort
mopv
lasv
design
protect
rodent
primat
lasv
challeng
appear
attenu
mopv
gain
better
insight
lasvinduc
patholog
mechan
attenu
perform
gene
express
profil
human
peripher
blood
mononuclear
cell
pbmc
expos
lasv
vaccin
candid
pbmc
healthi
human
subject
expos
either
lasv
although
pbmc
nonpermiss
viru
replic
remain
suscept
signal
transduct
viru
particl
total
rna
extract
global
gene
express
evalu
first
hour
use
highdens
microarray
result
valid
use
rtpcr
flow
cytometri
elisa
lasv
elicit
differenti
express
interferonstimul
gene
isg
well
gene
involv
apoptosi
nfkb
signal
coagul
pathway
gene
could
eventu
serv
biomark
predict
diseas
outcom
remark
differenti
express
thrombomodulin
key
regul
inflamm
coagul
suggest
involv
vascular
abnorm
mortal
lassa
fever
diseas
lassa
fever
lf
one
neglect
tropic
diseas
second
highest
global
incid
viral
hemorrhag
fever
vhf
dengu
hf
estim
risk
popul
sierra
leon
guinea
nigeria
may
high
million
number
symptomat
case
per
year
around
death
lf
also
one
promin
import
vhf
affect
public
health
nonendem
countri
worldwid
classifi
categori
biothreat
agent
lassa
viru
lasv
belong
arenavirida
fastgrow
famili
rodentborn
virus
current
includ
envelop
virus
biseg
ambisens
singlestrand
rna
genom
divid
two
group
old
world
ow
group
contain
prototyp
lymphocyt
choriomening
viru
lcmv
caus
neuropatholog
adult
fetal
abnorm
newborn
fatal
lflike
diseas
immunocompromis
patient
ow
virus
also
includ
lasv
nonpathogen
virus
mopeia
mopv
mobala
mobv
ippi
ippyv
well
newlyfound
lujo
pathogen
luna
unknown
pathogen
virus
new
world
group
includ
machupo
guanarito
sabia
chapar
virus
associ
sever
vhf
south
america
diseas
mechan
lf
still
clearli
understood
vhf
event
determin
lf
fatal
outcom
occur
earli
diseas
depend
host
immun
system
macrophag
mp
dendrit
cell
dc
initi
target
infect
follow
virem
seed
wide
varieti
cell
organ
high
viremia
elev
level
ast
plasma
two
major
risk
factor
predict
fatal
outcom
although
consist
patholog
find
hepatocellular
necrosi
extent
liver
damag
usual
insuffici
implic
hepat
failur
caus
death
function
damag
platelet
endotheli
cell
seem
play
import
role
howev
contribut
proand
antiinflammatori
stimuli
lf
pathogenesi
clearli
understood
laboratori
other
show
lasv
infect
associ
suppress
proinflammatori
respons
contribut
uncheck
viremia
fatal
outcom
studi
lf
pathogenesi
complic
absenc
reliabl
valid
anim
model
use
surrog
model
lf
rhesu
macaqu
inocul
strain
lcmv
show
earli
transcript
chang
blood
mostli
gene
involv
complement
interferon
proinflammatori
pathway
discrimin
virul
nonvirul
infect
approv
lf
vaccin
therapeut
option
limit
intraven
oral
ribavirin
often
impract
endem
area
vaccin
candid
reassort
contain
l
genom
segment
replic
gene
mopv
segment
encod
major
structur
protein
lasv
eighteen
mutat
distinguish
genom
parent
arenavirus
like
contribut
attenu
anim
model
broadli
crossprotect
divers
strain
lasv
abl
elicit
lasvspecif
immun
monkey
model
aid
current
studi
directli
expos
human
pbmc
healthi
donor
lasv
deriv
use
pbmc
profil
previous
show
elicit
less
inflammatori
gene
express
mopv
recapitul
similar
profil
primat
sivinfect
macaqu
human
pbmc
expos
viru
model
virem
stage
infect
vivo
much
transcriptom
respons
due
noninfecti
signal
transduct
viral
particl
pbmc
use
studi
rather
cell
line
close
simul
situat
vivo
circul
blood
cell
expos
virusinfect
site
shown
vitro
pbmc
exposur
arenavirus
differ
pathogen
potenti
lasv
result
differenti
express
isg
apoptot
nfkb
coagul
pathway
gene
virus
cell
lasv
strain
josiah
obtain
cdc
atlanta
ga
previous
describ
vero
cell
atcc
cultur
dulbecco
modifi
eagl
medium
dmem
gibcobrl
supplement
fetal
bovin
serum
fb
gibcobrl
penicillinstreptomycin
lglutamin
mm
incub
co
hour
vero
cell
monolay
infect
lasv
multipl
infect
moi
incub
hour
co
wash
pb
cover
dmem
fb
supernat
collect
hour
post
infect
titrat
vero
cell
store
pfuml
human
pbmc
obtain
apheresi
healthi
volunt
follow
ficollhypaqu
isol
resuspend
rpmi
medium
heatinactiv
human
ab
serum
sigma
monocyt
isol
purifi
pbmc
plastic
adher
immatur
dendrit
cell
dc
gener
day
cultur
supplement
rpmi
briefli
method
gener
dc
plate
human
pbmc
mlwell
plate
rpmi
fetal
calf
serum
hr
nonadher
cell
remov
adher
monocyt
fed
ml
rpmi
contain
ngml
gmcsf
peprotech
rocki
hill
nj
ngml
peprotech
day
incub
cell
harvest
analyz
flow
cytometri
process
incub
viru
averag
cell
differenti
monocytederiv
dc
dr
human
blood
sampl
use
irb
exempt
dr
salvato
use
deidentifi
human
cell
obtain
red
cross
human
pbmc
dc
exposur
pbmc
healthi
donor
expos
moi
lasv
facil
sfbr
san
antonio
tx
minut
co
plate
well
plate
duplic
supernat
cell
harvest
hour
postexposur
cell
resuspend
trizol
kept
rna
isol
dc
healthi
donor
expos
moi
lasv
lp
inhibitor
control
lp
usual
posit
control
use
inhibit
thrombomodulin
minut
co
facil
cdc
atlanta
ga
supernat
cell
harvest
hour
postexposur
supernat
kept
elisa
analysi
gene
express
profil
use
cdna
microarray
total
rna
isol
pmbc
sampl
use
trizol
method
invitrogen
carlsbad
ca
follow
clean
step
rneasi
mini
kit
qiagen
valencia
ca
accord
manufactur
instruct
qualiti
quantiti
rna
sampl
evalu
agil
bioanalyz
system
agil
technolog
palo
alto
ca
look
rrna
peak
rin
rna
integr
number
high
qualiti
rna
label
hybrid
accord
affymetrix
protocol
use
genechip
human
genom
plu
array
affymetrix
santa
clara
ca
describ
previous
chip
cover
whole
human
genom
use
probe
set
repres
approxim
gene
virul
lassa
fever
viru
lasv
nonpathogen
mopeia
viru
mopv
infect
rodent
incident
peopl
west
africa
mechan
lasv
damag
human
be
unclear
licens
lassa
fever
vaccin
therapeut
intervent
usual
late
vaccin
candid
deriv
lassa
mopeia
virus
protect
rodent
primat
lassa
fever
diseas
peripher
blood
mononuclear
cell
healthi
human
subject
expos
either
lasv
order
identifi
earli
cellular
respons
could
attribut
differ
virul
two
virus
differenti
express
interferonstimul
gene
well
coagulationrel
gene
could
lead
explan
lassa
fever
pathogenesi
indic
protect
treatment
lassa
fever
diseas
imag
hybrid
inspect
manual
percentag
present
call
array
check
cluster
princip
compon
analys
pca
condit
use
gene
normal
maximum
valueminimum
valu
also
perform
raw
data
array
normal
probe
level
use
robust
multichip
averag
gc
content
algorithm
gcrma
transform
detect
call
present
margin
absent
probeset
obtain
use
affymetrix
genechip
oper
softwar
gco
http
wwwaffymetrixcombrowseproduct
jsp
productid
navmod
navact
jump
aid
productsnav
gene
least
one
present
call
across
compar
hybrid
select
statist
analysi
data
submit
seri
record
identif
differentiallyexpress
gene
linear
model
microarray
data
limma
packag
use
due
high
variat
among
donor
pairwis
comparison
signific
analysi
microarray
sam
use
elimin
disturb
pbmc
donor
compar
exposur
differ
time
point
identifi
overrepres
gene
ontolog
go
term
list
differenti
express
gene
donor
repetit
go
termfind
use
go
term
adjust
p
valu
fals
discoveri
rate
fdr
less
select
order
identifi
overrepres
pathway
list
differenti
express
gene
donor
repetit
kegg
pathway
adjust
p
valu
fdr
less
list
gene
use
due
high
number
interferonrel
gene
involv
lasv
gene
profil
select
valid
rtpcr
hour
postexposur
hpe
rna
sampl
donor
time
point
use
microarray
test
evalu
interferon
receptor
pcr
array
kit
human
interferon
receptor
array
cat
sabiosci
frederick
md
platform
test
interferonrel
gene
housekeep
gene
data
normal
briefli
mg
rna
pbmc
reversetranscrib
reaction
volum
firststrand
cdna
use
superarray
reactionreadi
first
strand
cdna
synthesi
kit
cat
sabiosci
contain
random
oligo
dt
primer
mix
cdna
sybr
green
rox
qpcr
master
mix
cat
sabiosci
ml
cdna
mixtur
dispens
well
format
plate
rt
profil
pcr
array
cat
sabiosci
realtim
pcr
perform
abi
fast
realtim
pcr
system
appli
biosystem
foster
citi
ca
use
follow
cycl
paramet
min
heat
activ
step
cycl
sec
min
rel
chang
gene
express
calcul
use
ddc
threshold
cycl
method
method
first
subtract
ct
threshold
cycl
number
geneaverag
ct
hous
keep
gene
array
normal
rna
amount
final
ddct
calcul
involv
subtract
normal
averag
ct
lasv
sampl
normal
averag
ct
control
sampl
ddct
rais
neg
power
order
calcul
fold
chang
p
valu
calcul
use
student
test
result
treat
sam
data
analysi
avoid
donor
variat
whole
blood
healthi
donor
collect
heparin
tube
mix
ngml
lipopolysaccharid
lp
cat
notlrlekpl
invivogen
san
diego
ca
downregul
control
thrombomodulin
mem
nonstimul
control
viru
mix
brought
ml
rpmi
fb
incub
hour
timepoint
cell
stain
phycoerytrhinconjug
mous
antihuman
thrombomodulin
monoclon
antibodi
bd
bioscienc
san
jose
ca
fluorescein
isothiocyan
mous
antihuman
antibodi
bd
bioscienc
san
jose
ca
cell
collect
event
per
sampl
use
facscalibur
cytomet
bd
bioscienc
data
analyz
use
flowjo
softwar
tree
star
san
carlo
ca
monocyt
popul
gate
percentag
doubl
posit
cell
determin
dendrit
cell
isol
differ
individu
viru
exposur
express
solubl
thrombomodulin
immatur
dc
deriv
human
pbmc
describ
virus
cell
solubl
thrombomodulin
quantifi
elisa
human
thrombomodulin
elisa
kit
cat
abcam
cambridg
dc
supernat
hour
exposur
lp
lasv
lasv
plu
lp
plate
read
nm
use
spectramax
elisa
reader
molecular
devic
corpor
sunnyval
ca
estim
amount
thrombomodulin
calcul
use
softmax
pro
program
molecular
devic
corpor
sunnyval
ca
present
picogram
per
ml
previou
transcriptom
profil
studi
use
surrog
lf
model
monkey
show
signific
chang
pbmc
gene
express
occur
previrem
day
clearli
differenti
pathogen
versu
nonpathogen
infect
even
detect
viru
replic
clearli
larg
part
respons
virus
due
signal
transduct
uninfect
bystand
cell
studi
pbmc
three
healthi
donor
expos
lasv
virus
moi
duplic
collect
hour
postexposur
hpe
isol
total
rna
cdna
hybrid
affymetrix
chip
cover
whole
human
genom
cluster
princip
compon
analysi
pca
show
sampl
cluster
togeth
time
hpe
donor
healthi
donor
treatment
unexpos
lasvexpos
cell
figur
sinc
donor
variat
exceed
treatment
variat
pairwis
signific
analysi
microarray
sam
use
compar
rna
sampl
exposur
donor
differ
time
point
differentiallyexpress
gene
defin
least
chang
respect
media
control
total
gene
identifi
differenti
express
test
timepoint
figur
tabl
gene
express
chang
lasvexpos
pbmc
detect
hpe
respect
gene
upregul
lasv
contrast
downregul
gene
hpe
hpe
hpe
lasvtreat
pbmc
show
maximum
chang
gene
comparison
sampl
gene
ontolog
analysi
global
chang
lasv
versu
pbmc
order
gener
view
pathway
affect
viru
exposur
perform
gene
ontolog
go
analysi
differenti
express
gene
analys
reveal
affect
gene
involv
type
ifnstimul
pathway
gene
apoptosi
nfkappa
b
pathway
figur
although
sever
gene
could
put
one
categori
interferonrel
gene
higher
percentag
presenc
categori
immun
respons
defens
respons
respons
virus
select
valid
analysi
tabl
differenti
express
gene
lasv
shown
tabl
lasv
exposur
upregul
gene
involv
innat
immun
ifnstimul
gene
transcript
factor
gene
involv
apoptosi
shown
figur
strike
differ
involv
gene
express
three
differ
function
categori
ifnstimul
apoptosi
nfkb
pathway
late
timepoint
h
exposur
confirm
observ
gene
express
chang
pbmc
expos
lasv
virus
affect
probeset
isg
select
valid
rna
sampl
lasvand
cell
assay
duplic
use
human
ifn
receptor
qrtpcr
superarray
kit
see
method
level
express
genetarget
express
fold
chang
tabl
figur
exposur
human
pbmc
lasv
result
overexpress
ifnstimul
gene
background
exposur
pbmc
rel
littl
effect
test
gene
compar
analys
show
good
correl
two
techniqu
dna
array
ifn
qrtpcr
array
tabl
gene
measur
dna
array
exposur
gave
higher
background
quantit
realtim
pcr
housekeep
gene
use
normal
pcr
data
includ
gapdh
constantli
express
compar
data
set
wherea
probeset
use
normal
microarray
data
vari
less
data
set
see
method
affect
gene
first
ifnstimul
gene
known
inhibit
apoptosi
among
affect
gene
function
gene
welldefin
ifitm
protein
role
immun
cell
signal
adhes
cancer
germ
cell
physiolog
bone
miner
ifitm
also
viral
restrict
factor
block
entri
influenza
ebola
dengu
west
nile
virus
arenavirusenvelop
pseudotyp
particl
overexpress
lasvexpos
pbmc
other
found
could
upregul
lasvinfect
monocytederiv
macrophag
also
known
limit
burst
size
lcmv
cultur
tabl
supplement
materi
green
color
repres
downregul
gene
twofold
compar
nonexpos
control
red
color
repres
upregul
gene
twofold
compar
nonexpos
control
ultim
essenti
lcmv
clearanc
vivo
transcript
factor
togeth
nfkb
induc
product
ifni
requir
activ
ifnb
turn
prime
express
ifna
gene
ifninduc
pathway
human
play
import
role
resist
intracellular
pathogen
human
mycobacteria
intracellular
cancer
recent
cellular
protein
describ
mediat
interact
viral
protein
viral
infect
among
apoptosisrel
gene
strike
differ
observ
express
matrix
metalloproteinas
interstiti
collagenas
upregul
lasvexpos
cell
versu
cell
tabl
protein
mmp
famili
normal
breakdown
extracellular
matrix
embryon
develop
reproduct
tissu
remodel
well
diseas
process
arthriti
metastasi
known
interact
tat
hiv
transactiv
protein
interact
result
degrad
tat
depress
tatmedi
neurotox
transactiv
two
apoptosisrel
gene
inhba
upregul
respect
tabl
secret
arginineglycineaspart
rgd
contain
phosphoprotein
previou
name
osteopontin
bone
sialoprotein
enhanc
ifnc
product
contribut
host
defens
bone
format
wound
heal
stimul
macrophag
migrat
well
protect
viral
bacteri
infect
effect
inhibinbeta
inhba
join
inhibinalpha
form
pituitari
folliclestimul
hormon
fsh
secret
inhibitor
inhibin
shown
negativelyregul
gonad
stromal
cell
prolifer
tumorsuppressor
activ
inhba
also
upregul
vaccinia
inhibit
divers
array
cytokin
enabl
vaccinia
viru
protein
antagon
sever
distinct
interlink
signal
cascad
exposur
human
pbmc
lasv
associ
strong
upregul
gene
comparison
exposur
tabl
among
cxc
chemokin
granulocyt
chemotact
share
highest
function
homolog
exhibit
dispar
regulatori
effect
recruit
neutrophil
respons
due
natur
lf
diseas
six
lasvupregul
gene
relat
coagul
pathway
analyz
tabl
thrombomodulin
thbd
heparinbind
growth
factor
hbgf
integrin
alpha
itgam
upregul
lasv
exposur
timepoint
contrast
downregul
plasminogen
activ
urokinas
plau
integrin
mostli
upregul
lasv
exposur
remain
unchang
downregul
pdecgf
tymp
slightli
upregul
exposur
virus
analysi
coagulationrel
gene
use
gene
ontolog
go
softwar
show
interact
gene
relat
immun
respons
figur
order
valid
cdna
array
result
thbd
express
measur
surfac
exposedmonocyt
flow
cytometri
quantifi
elisa
supernat
dc
expos
lasv
signific
chang
thrombomodulin
express
cell
pbmc
treat
lp
compar
nontreat
cell
hpe
data
shown
howev
shown
figur
signific
reduct
thbd
express
surfac
cell
lp
control
hpe
hpe
stimulu
control
hpe
hpe
agreement
microarray
result
show
lower
thbd
rna
pbmc
figur
tabl
dc
cultur
expos
lasv
secret
significantli
higher
level
thbd
dc
expos
figur
agreement
transcriptom
data
control
dc
secret
pgml
thbd
wherea
lassaexpos
dc
express
pgml
thbd
significantli
dc
pgml
treatment
lasv
lp
togeth
diminish
thbd
express
pgml
lasv
exposur
pgml
coagulationrel
gene
could
also
contribut
lf
diseas
plasminogen
activ
urokinas
plau
express
could
contribut
anticlot
effect
mediat
lasv
exposur
heparinbind
epiderm
growth
factorlik
hbegf
express
involv
sever
blood
vessel
physiolog
kidney
patholog
inhibit
nfkappa
b
activ
cardiac
hypertrophi
togeth
pdecgf
promot
vascular
matur
platelet
marker
upregul
cell
expos
lasv
h
integrin
integr
cellsurfac
protein
compos
b
chain
given
chain
may
combin
multipl
partner
result
differ
integrin
found
along
aiib
chain
platelet
work
receptor
fibrinogen
von
willebrand
factor
plasminogen
prothrombin
thrombospondin
fibronetin
osteospontin
vitronectin
integrin
known
particip
cell
adhes
well
cellsurfac
mediat
signal
high
affin
lasv
bind
cellular
alphadystroglycan
adg
receptor
perturb
signal
cross
cell
surfac
thbd
detect
flow
cytometri
gate
cell
experi
repeat
pbmc
differ
healthi
donor
similar
result
exposur
either
lp
cellsurfac
thbd
downregul
approxim
hour
post
exposur
hpe
accord
pair
student
test
downregul
signific
timepoint
b
solubl
thbd
measur
elisa
dendrit
cell
supernat
expos
lp
inhibitor
lasv
lasv
plu
lp
hpe
standard
deviat
thbd
concentr
shown
three
differ
experi
thmd
cell
significantli
depress
respect
thbd
nonexpos
control
cell
lassaexpos
cell
express
significantli
thbd
cell
talk
dg
integrin
shift
normal
signal
equilibrium
toward
inhibit
mekerk
pathway
dg
ubiquit
receptor
extracellular
matrix
ecm
protein
cooper
integrin
control
cellmatrix
interact
paper
postreview
malhotra
et
al
publish
result
transcriptom
profil
pbmc
cynomolg
macaqu
infect
lasv
result
good
correl
current
studi
previou
result
lcmvinfect
monkey
model
lf
tabl
would
expect
pbmc
exposur
rna
virus
transcriptom
analysi
show
set
ifnstimul
gene
isg
affect
exposur
lasv
antiviralisg
includ
common
group
upregul
gene
influenza
infect
yellow
fever
vaccin
febril
episod
dengu
hemorrhag
fever
comparison
strong
upregul
lasv
mute
express
inhba
neg
regul
ifnc
trail
rige
gene
interferon
pathway
well
gene
relat
immun
respons
integrin
itgam
gene
downregul
hpe
suggest
mechan
avoid
recognit
innat
immun
system
interfer
essenti
signal
pathway
lead
develop
type
immun
exampl
interferonalphabeta
induc
involv
antivir
action
type
interferon
downregul
probabl
allow
viru
replic
earli
infect
strong
immun
respons
control
viral
replic
spread
support
notion
antivir
gene
viperin
express
lasv
pbmc
lasv
upregul
homolog
well
three
gene
control
cell
traffick
monocyteattract
chemokin
monocyt
chemotact
mannos
receptor
c
type
vitro
respons
may
relat
clinic
observ
higher
serum
level
patient
acut
nonfat
lf
control
subject
level
proinflammatori
cytochemokin
tnfa
low
undetect
patient
fatal
lf
support
previou
observ
primari
human
cell
observ
also
confirm
anim
model
fatal
lf
provid
evid
type
cytokin
storm
observ
filoviru
hf
idea
uncontrol
replic
lasv
target
cell
dc
macrophag
associ
mark
suppress
innat
adapt
immun
respons
result
clinic
progress
death
experiment
anim
lf
patient
wellaccept
concept
bleed
salient
manifest
case
lf
contrast
south
american
arenavir
hf
caus
machupo
virus
dissemin
intravascular
coagul
dic
rare
seen
lf
patient
nevertheless
virusinduc
coagul
abnorm
impair
vascular
function
hallmark
lf
pathogenesi
platelet
remain
either
normal
moder
low
significantli
reduc
function
plasma
lf
patient
inhibitori
activ
platelet
healthi
individu
suggest
presenc
solubl
factor
caus
platelet
malfunct
previou
work
support
notion
lasv
replic
vigor
endotheli
cell
without
cytopath
effect
reduc
cell
function
reduc
product
interleukin
lymphopenia
impair
lymphocyt
prolif
respons
also
characterist
sever
lassa
fever
consequ
addit
hematopoiet
effect
solubl
factor
lymphocyt
apoptosi
due
lasv
upregul
inhba
may
contribut
lassa
pathogenesi
coagul
defect
associ
lf
diseas
could
potenti
affect
lasvupregul
six
coagulationrel
gene
notabl
thrombomodulin
thbd
thbd
predominantli
synthes
vascular
endotheli
cell
kda
type
transmembran
protein
inhibit
thrombot
inflammatori
redox
relat
respons
thbd
form
molar
complex
thrombin
significantli
enhanc
rate
thrombin
inactiv
atiii
acceler
activ
protein
c
apc
observ
level
secret
thbd
dendrit
cell
dc
cultur
medium
correl
transcriptom
data
dc
exposur
lasv
upregul
secret
thbd
wherea
exposur
opposit
effect
notabl
lp
treatment
lasvexpos
cell
result
lower
thbd
well
presenc
thrombin
thbd
gener
apc
inhibit
procoagul
proinflammatori
respons
includ
fibrinogen
cleavag
factor
v
activ
platelet
activ
local
cytokineinduc
chemotaxi
monocyt
neutrophil
upregul
leukocyt
adhes
molecul
shown
thbd
mrna
halflif
shorten
treatment
cell
ifnc
observ
addit
lasvincreas
thbd
express
seen
absenc
ifn
respons
seen
vitro
agreement
lf
find
clear
inflammatori
respons
cellular
infiltr
conjunct
high
viral
load
seen
presenc
hemorrhag
symptom
absenc
thbd
upregul
lcmvwe
infect
model
lf
may
key
fail
model
see
detail
tabl
current
hypothesi
lasv
infect
endotheli
antigenpres
cell
increas
express
membran
solubl
thbd
form
activ
apc
captur
antiinflammatori
anticoagul
effect
figur
upregul
thbd
consequ
anticoagul
effect
could
also
explain
fibrin
deposit
rare
seen
histolog
examin
tissu
lf
patient
dissemin
intravascular
coagul
dic
rare
lf
frequent
observ
viral
hemorrhag
fever
given
result
inhibit
thbd
could
potenti
therapeut
intervent
lf
lasvinduc
perturb
crosstalk
integrin
extracellular
matrix
may
contribut
function
alter
epitheli
vascular
endotheli
cell
preced
shock
death
lf
patient
also
possibl
high
state
viremia
lasv
bind
directli
platelet
inhibit
function
arteri
injuri
leukocyt
recruit
site
increas
itgam
express
allow
adhes
platelet
fibrinogen
vessel
wall
propos
lasv
induct
itgam
could
increas
platelet
adhes
tissu
may
explain
decreas
number
circul
platelet
hemorrhag
episod
plateletderiv
endotheli
cell
growth
factor
pdecgf
involv
angiogenesi
wound
repair
differenti
express
gene
may
contribut
nonpathogen
phenotyp
pathogen
phenotyp
lasv
lasvinfect
primat
dc
macrophag
identifi
promin
target
earli
stage
infect
kupffer
cell
hepatocyt
adren
cortic
cell
endotheli
cell
frequent
infect
late
stage
show
previous
mononuclear
cell
pbmc
permiss
lasv
viru
replic
differenti
monocyt
dc
macrophag
repres
less
circul
pbmc
sinc
lasv
replic
rate
monocytederiv
cultur
isl
unpublish
differenti
gene
express
report
like
due
differenti
signal
uninfect
bystand
cell
virus
lasv
ident
surfaceexpos
respons
interact
adg
howev
lasv
differ
lysin
glutam
acid
substitut
locat
fusion
domain
rrll
motif
cellular
subtilas
cleavag
site
amount
neg
charg
site
greater
arenavir
could
potenti
affect
fusion
signal
summari
exposur
human
pbmc
virus
model
virem
stage
diseas
reveal
clear
differ
respons
lasv
attenu
remain
shown
whether
charg
differ
lasv
protein
account
differ
transcriptom
profil
isg
gene
involv
apoptot
nfkb
pathway
among
lasvaffect
gene
h
exposur
lasv
also
affect
gene
involv
coagul
pathway
eg
lasv
strongli
upregul
thbd
suggest
connect
vascular
abnorm
fatal
case
lf
base
current
knowledg
thbd
involv
procoagul
proinflammatori
pathway
thbd
inhibit
could
promis
drug
target
addit
import
investig
immun
responserel
gene
elucid
protect
mechan
undermin
lf
pathogenesi
figur
cluster
analysi
show
sampl
cluster
togeth
time
hpe
donor
healthi
donor
treatment
unexpos
lasvexpos
cell
sampl
id
organ
timedonorstimulussampl
number
red
color
repres
upregul
gene
green
color
repres
downregul
gene
tif
tabl
total
gene
identifi
differenti
express
test
timepoint
appear
tabl
due
use
one
probe
detect
gene
column
show
affymetrix
gene
name
column
b
correspond
probe
identif
refer
column
c
e
comparison
lasv
exposur
unexpos
cell
differ
time
point
column
f
h
comparison
unexpos
cell
differ
time
point
column
unigen
id
number
column
j
genbank
access
number
number
indic
foldchang
gene
express
compar
control
red
color
repres
signific
upregul
gene
green
color
repres
signific
downregul
gene
tif
tabl
sam
analysi
rna
profil
pbmc
expos
lasv
vitro
compar
rna
profil
pbmc
wearm
infect
monkey
gene
common
pattern
differ
pattern
hpe
navi
blue
highlight
indic
discrep
transcriptom
pair
lcmvwearm
pair
yellow
highlight
indic
interferon
pathway
gene
coagulationrel
gene
tif
author
contribut
